117 related articles for article (PubMed ID: 15988914)
1. ABT-751 (Abbott).
Galmarini CM
Curr Opin Investig Drugs; 2005 Jun; 6(6):623-30. PubMed ID: 15988914
[No Abstract] [Full Text] [Related]
2. Synthesis of anti-microtubule N-(2-Arylindol-7-yl)benzenesulfonamide derivatives and their antitumor mechanisms.
Chiou CT; Chen GS; Chen ML; Li H; Shi L; Huang XH; Dai WM; Chern JW
ChemMedChem; 2010 Sep; 5(9):1489-97. PubMed ID: 20672297
[No Abstract] [Full Text] [Related]
3. Novel potent antimitotic heterocyclic ketones: synthesis, antiproliferative activity, and structure-activity relationships.
Hu L; Jiang JD; Qu J; Li Y; Jin J; Li ZR; Boykin DW
Bioorg Med Chem Lett; 2007 Jul; 17(13):3613-7. PubMed ID: 17482458
[TBL] [Abstract][Full Text] [Related]
4. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
5. Novel benzopyridothiadiazepines as potential active antitumor agents.
Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
[TBL] [Abstract][Full Text] [Related]
6. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
7. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
[TBL] [Abstract][Full Text] [Related]
8. [The DACA].
Lansiaux A; Adams A; Denny WA; Bailly C
Bull Cancer; 1999 Dec; 86(12):971-5. PubMed ID: 10660691
[No Abstract] [Full Text] [Related]
9. N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide as a novel tubulin ligand against human cancer.
Wang YM; Hu LX; Liu ZM; You XF; Zhang SH; Qu JR; Li ZR; Li Y; Kong WJ; He HW; Shao RG; Zhang LR; Peng ZG; Boykin DW; Jiang JD
Clin Cancer Res; 2008 Oct; 14(19):6218-27. PubMed ID: 18829501
[TBL] [Abstract][Full Text] [Related]
10. Benzoylphenylurea sulfur analogues with potent antitumor activity.
Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
[TBL] [Abstract][Full Text] [Related]
11. Tasidotin HCl (Genzyme).
Rasila KK; Verschraegen C
Curr Opin Investig Drugs; 2005 Jun; 6(6):631-8. PubMed ID: 15988915
[No Abstract] [Full Text] [Related]
12. The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer .
Folkes AJ; Ahmadi K; Alderton WK; Alix S; Baker SJ; Box G; Chuckowree IS; Clarke PA; Depledge P; Eccles SA; Friedman LS; Hayes A; Hancox TC; Kugendradas A; Lensun L; Moore P; Olivero AG; Pang J; Patel S; Pergl-Wilson GH; Raynaud FI; Robson A; Saghir N; Salphati L; Sohal S; Ultsch MH; Valenti M; Wallweber HJ; Wan NC; Wiesmann C; Workman P; Zhyvoloup A; Zvelebil MJ; Shuttleworth SJ
J Med Chem; 2008 Sep; 51(18):5522-32. PubMed ID: 18754654
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
Reddy GR; Kuo CC; Tan UK; Coumar MS; Chang CY; Chiang YK; Lai MJ; Yeh JY; Wu SY; Chang JY; Liou JP; Hsieh HP
J Med Chem; 2008 Dec; 51(24):8163-7. PubMed ID: 19053773
[TBL] [Abstract][Full Text] [Related]
14. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
15. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
Zask A; Kaplan J; Musto S; Loganzo F
J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
[TBL] [Abstract][Full Text] [Related]
16. Discovery and structure-activity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers.
Zhang HZ; Crogan-Grundy C; May C; Drewe J; Tseng B; Cai SX
Bioorg Med Chem; 2009 Apr; 17(7):2852-8. PubMed ID: 19282188
[TBL] [Abstract][Full Text] [Related]
17. The epothilones: how pharmacology relates to clinical utility.
Michaud LB
Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
[TBL] [Abstract][Full Text] [Related]
18. Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies.
Putey A; Popowycz F; Do QT; Bernard P; Talapatra SK; Kozielski F; Galmarini CM; Joseph B
J Med Chem; 2009 Oct; 52(19):5916-25. PubMed ID: 19743863
[TBL] [Abstract][Full Text] [Related]
19. Resisting a fundamentalist policy.
Castro M
J Clin Oncol; 2005 May; 23(15):3645-6; author reply 3646-8. PubMed ID: 15908688
[No Abstract] [Full Text] [Related]
20. Microtubules: a dynamic target in cancer therapy.
Pasquier E; Kavallaris M
IUBMB Life; 2008 Mar; 60(3):165-70. PubMed ID: 18380008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]